Literature DB >> 8500568

Characterization of adenosine A2 receptors in bovine retinal pigment epithelial membranes.

C Blazynski1.   

Abstract

The pharmacological characteristics of adenosine A2 receptors are described for membranes prepared from bovine retinal pigmented epithelial (RPE) cells. RPE cells were isolated after removal of retina, lysed by freeze-thawing, and membranes separated from cytoplasmic components. A single population of adenosine binding sites is present in RPE membranes, as determined from saturation analysis and competition binding assays. From Scatchard plots, this single class of binding sites exhibited low affinity for adenosine receptor agonists. These low affinity sites were labeled by [3H]-N-ethylcarboxamido-adenosine (NECA) or [3H]-CGS 21680 and Kds of 423 and 5.3 microM were determined for each radioligand, respectively. NECA-mediated stimulation of adenylate cyclase demonstrated that these binding sites represent adenosine receptors. No high affinity A2a binding sites were detected in RPE membranes by either saturation studies, or by competition with adenosine A1-selective agonists which only displaced radioligand binding at high micromolecular concentrations. The low affinity A2 receptor on RPE differs from the high affinity A2a receptor characterized in bovine retinal membranes, but may be similar or identical to the lower affinity A2b receptor detected in retinal membranes as well as other tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500568     DOI: 10.1006/exer.1993.1073

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  12 in total

1.  Release of ATP by a human retinal pigment epithelial cell line: potential for autocrine stimulation through subretinal space.

Authors:  C H Mitchell
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

2.  Adenosine receptor distribution in Rhesus monkey ocular tissue.

Authors:  Krista M Beach; Li-Fang Hung; Baskar Arumugam; Earl L Smith; Lisa A Ostrin
Journal:  Exp Eye Res       Date:  2018-05-21       Impact factor: 3.467

Review 3.  Adverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protection.

Authors:  Scott A Rivkees; Christopher C Wendler
Journal:  Pediatr Res       Date:  2011-04       Impact factor: 3.756

4.  Extracellular ATP activates calcium signaling, ion, and fluid transport in retinal pigment epithelium.

Authors:  W M Peterson; C Meggyesy; K Yu; S S Miller
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

Review 5.  Regulation of cardiovascular development by adenosine and adenosine-mediated embryo protection.

Authors:  Scott A Rivkees; Christopher C Wendler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

6.  Purinergic regulation of cation conductances and intracellular Ca2+ in cultured rat retinal pigment epithelial cells.

Authors:  J S Ryan; W H Baldridge; M E Kelly
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

Review 7.  Long-term consequences of disrupting adenosine signaling during embryonic development.

Authors:  Scott A Rivkees; Christopher C Wendler
Journal:  Mol Aspects Med       Date:  2017-02-13

8.  Assessment of exonic single nucleotide polymorphisms in the adenosine A2A receptor gene to high myopia susceptibility in Chinese subjects.

Authors:  Xiaoyan Chen; Anquan Xue; Wei Chen; Yang Ding; Dongsheng Yan; Jiqing Peng; Changqing Zeng; Jia Qu; Xiangtian Zhou
Journal:  Mol Vis       Date:  2011-02-16       Impact factor: 2.367

9.  Purinergic signalling in the subretinal space: a role in the communication between the retina and the RPE.

Authors:  Claire H Mitchell; David Reigada
Journal:  Purinergic Signal       Date:  2007-03-14       Impact factor: 3.765

10.  Voltage-dependent calcium channel CaV1.3 subunits regulate the light peak of the electroretinogram.

Authors:  Jiang Wu; Alan D Marmorstein; Jörg Striessnig; Neal S Peachey
Journal:  J Neurophysiol       Date:  2007-03-21       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.